Patent: 8,691,321
✉ Email this page to a colleague
Summary for Patent: 8,691,321
Title: | Bioabsorbable polymeric composition and medical device background |
Abstract: | A method for fabricating an embodiment of a medical device comprising the steps of: preparing a biodegradable polymeric structure; coating the biodegradable polymeric structure with a polymeric coat including a pharmacological or biological agent; cutting the structure into patterns configured to allow for crimping of the cut structure and expansion of the cut structure after crimping into a deployed configuration. |
Inventor(s): | Cottone; Robert J. (Davie, FL) |
Assignee: | Orbusneich Medical, Inc. (Fort Lauderdale, FL) |
Application Number: | 11/875,892 |
Patent Claims: | see list of patent claims |
Details for Patent 8,691,321
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 12/31/2002 | ⤷ Try a Trial | 2039-03-29 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 02/21/2008 | ⤷ Try a Trial | 2039-03-29 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 04/24/2013 | ⤷ Try a Trial | 2039-03-29 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 09/23/2014 | ⤷ Try a Trial | 2039-03-29 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 11/23/2015 | ⤷ Try a Trial | 2039-03-29 |
Abbvie Inc. | HUMIRA | adalimumab | Injection | 125057 | 03/09/2016 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |